Ackerman Capital Advisors LLC reduced its holdings in UnitedHealth Group Inc (NYSE:UNH) by 25.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,500 shares of the healthcare conglomerate’s stock after selling 500 shares during the quarter. UnitedHealth Group comprises 1.6% of Ackerman Capital Advisors LLC’s investment portfolio, making the stock its 17th largest position. Ackerman Capital Advisors LLC’s holdings in UnitedHealth Group were worth $441,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of UNH. Selective Wealth Management Inc. purchased a new position in shares of UnitedHealth Group in the third quarter worth $27,000. North Star Investment Management Corp. purchased a new stake in UnitedHealth Group during the third quarter valued at $30,000. Delta Asset Management LLC TN increased its position in UnitedHealth Group by 111.0% during the third quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 81 shares during the last quarter. Fusion Family Wealth LLC increased its position in UnitedHealth Group by 329.7% during the third quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 122 shares during the last quarter. Finally, Massey Quick Simon & CO. LLC increased its position in UnitedHealth Group by 212.5% during the third quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after acquiring an additional 119 shares during the last quarter. Hedge funds and other institutional investors own 85.81% of the company’s stock.
Shares of UnitedHealth Group stock traded down $3.24 during trading on Friday, reaching $289.22. The company’s stock had a trading volume of 3,425,916 shares, compared to its average volume of 4,304,345. The company has a 50-day simple moving average of $291.46 and a two-hundred day simple moving average of $259.22. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $302.54. The company has a quick ratio of 0.70, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. The company has a market cap of $277.08 billion, a price-to-earnings ratio of 20.18, a P/E/G ratio of 1.43 and a beta of 0.69.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of UnitedHealth Group stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $299.45, for a total value of $4,491,750.00. Following the transaction, the director now owns 158,598 shares of the company’s stock, valued at approximately $47,492,171.10. The disclosure for this sale can be found here. Company insiders own 0.87% of the company’s stock.
UNH has been the subject of a number of research reports. UBS Group upped their price objective on UnitedHealth Group from $279.00 to $304.00 and gave the company a “neutral” rating in a research report on Thursday, January 16th. SunTrust Banks upped their price target on UnitedHealth Group from $335.00 to $350.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Credit Suisse Group upped their price target on UnitedHealth Group from $320.00 to $330.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 8th. Cantor Fitzgerald upped their price target on UnitedHealth Group from $315.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, January 16th. Finally, Argus reaffirmed a “buy” rating and issued a $340.00 price objective on shares of UnitedHealth Group in a research note on Thursday, December 19th. Five research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $313.50.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: How to Trade Using Analysts Ratings
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.